Status:

RECRUITING

A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body

Lead Sponsor:

Boehringer Ingelheim

Conditions:

Healthy

Eligibility:

All Genders

18-65 years

Phase:

PHASE1

Brief Summary

This study is open to healthy people between 18 and 65 years of age. People can join the study if they have a body mass index between 27 and 39.9 kg/m2. The purpose of this study is to test a new for...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Healthy male or female trial participant according to the assessment of the investigator, as based on a complete medical history including a physical examination, vital signs (blood pressure (BP), pulse rate (PR)), 12-lead electrocardiogram (ECG), and clinical laboratory tests
  • Age of 18 to 65 years (inclusive)
  • Body mass index (BMI) of 27.0 to 39.9 kg/m² (inclusive)
  • Signed and dated written informed consent in accordance with ICH-GCP and local legislation prior to admission to the trial Further inclusion criteria apply.
  • Exclusion criteria:
  • Any finding in the medical examination (including BP, PR or ECG) deviating from normal and assessed as clinically relevant by the investigator
  • Repeated measurement of systolic blood pressure outside the range of 90 to 150 mmHg, diastolic blood pressure outside the range of 50 to 100 mmHg, or pulse rate outside the range of 50 to 100 bpm
  • Any laboratory value outside the reference range that the investigator considers to be of clinical relevance
  • Any evidence of a concomitant disease assessed as clinically relevant by the investigator. Presence of hypertension, hypothyroidism, hyperuricaemia and hypercholesterolaemia are acceptable if well-controlled according to the investigator's judgement.
  • Further exclusion criteria apply.

Exclusion

    Key Trial Info

    Start Date :

    November 5 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    August 24 2026

    Estimated Enrollment :

    100 Patients enrolled

    Trial Details

    Trial ID

    NCT07221591

    Start Date

    November 5 2025

    End Date

    August 24 2026

    Last Update

    December 24 2025

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    CRS Clinical Research Services Berlin GmbH

    Berlin, Germany, 13627

    2

    CRS Clinical Research Services Mannheim GmbH

    Mannheim, Germany, 68167